U.S. Contraceptive Market Size, Revenue, Growth, Trend & Forecast Analysis, 2020 - 2027, By Product, By Country, & By Region

  • Report Id: HCDHR 2157
  • Published Date: August, 2020
  • No of Pages: 150
  • Format: Electronic (PDF)
  • Publisher: DataHorizzon Research
  • Category:

U.S. Contraceptive Market Report Overview

U.S. Contraceptive market garnered a revenue of USD 7.4 billion in the year 2019 globally and has been foreseen to grow at a compound annual growth (CAGR) of 4.5% over the forecast period. The market has been observed to be growing at a steady growth rate over the last three years, however with the impact of COVID-19 pandemic globally, the business conditions are expected to change. The market size may reduce significantly or increase with a spike depending on how the value chain has been affected in the entire process.

Players that are operational in the market for a longer period of time are anticipated to absorb the sudden changes, losses and increased operational costs better than those who have recently entered the market. The report focuses on numerous factors that are anticipated to impact the market growth directly and indirectly. The report categorically analyses the growth patterns of different segments based on multiple derivation models.

Both the qualitative and quantitative aspects have been covered under the report. The U.S. Contraceptive market report includes market size, drivers, restraints, opportunities and trends that will help you understand the market dynamics in detail. Moreover, the report will include market estimates & forecasts in terms of revenue for the overall market along with the segments mentioned in the study. The report focuses on providing a holistic view of the entire market scenario from multiple unmatched detailed analysis mentioned in the report.

What to expect from the report?

  • S. Contraceptive Total Available Market (TAM)Size
  • S. Contraceptive Serviceable Available Market (SAM) Size
  • Business Implications of COVID-19 on the Overall Market
  • Market Share/ Revenue Share (%) of Top Market Players in Total Market Size (2019)
  • Market Size & Forecast (2016-2027) At Country & Regional Level, By Segments
  • Overview & Analysis of Key Players Operating in the Market

Key Highlights:

Parameters

Description

COVID-19

Impact of COVID-19 on overall business scenario

U.S. Contraceptive Market Revenue 2020

Global market revenue in 2020 will be derived taking into various micro & macro level factors; along with COVID-19 pandemic

Competitive Analysis

Company Market Share Analysis, 2019 (%)

Supply Chain Analysis

Analysis pertaining to several participants of supply chain such as raw material suppliers, distributors, & OEMs along with others will be highlighted in the study

Data Source

Primary & Secondary Research, Internal Data Base & Company Annual Reports

Regions Included

North America,

Countries Included

U.S., Canada,

Table of Contents
Chapter 1. Research Methodology & Data Sources
1.1. Data Analysis Models
1.2. Research Scope & Assumptions
1.3. List of Primary & Secondary Data Sources
Chapter 2. Executive Summary
Chapter 3. U.S. Contraceptive Market: Industry Analysis
3.1. Market segmentation
3.2. Supply chain analysis
3.3. Porter’s 5 forces analysis
3.4. PEST analysis
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Market opportunity analysis
3.6. Company Market Share Analysis, 2019
Chapter 4. U.S. Contraceptive Market: Product Insights
4.1. Global Product Historic Market Data & Future Forecasts, 2016-2027
4.2. Pills
4.2.1. Historic Market Data & Future Forecasts, 2016-2027
4.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.3. Condoms
4.3.1. Historic Market Data & Future Forecasts, 2016-2027
4.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4. Male Condoms
4.4.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.5. Female Condoms
4.5.1. Historic Market Data & Future Forecasts, 2016-2027
4.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.6. Diaphragms
4.6.1. Historic Market Data & Future Forecasts, 2016-2027
4.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.7. Sponge
4.7.1. Historic Market Data & Future Forecasts, 2016-2027
4.7.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.8. Vaginal Ring
4.8.1. Historic Market Data & Future Forecasts, 2016-2027
4.8.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.9. Subdermal Implants
4.9.1. Historic Market Data & Future Forecasts, 2016-2027
4.9.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.10. IUD
4.10.1. Historic Market Data & Future Forecasts, 2016-2027
4.10.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.11. Hormonal IUD
4.11.1. Historic Market Data & Future Forecasts, 2016-2027
4.11.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.12. Nonhormonal IUD
4.12.1. Historic Market Data & Future Forecasts, 2016-2027
4.12.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.13. PItch
4.13.1. Historic Market Data & Future Forecasts, 2016-2027
4.13.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.14. Injectable
4.14.1. Historic Market Data & Future Forecasts, 2016-2027
4.14.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 5. U.S. Contraceptive Market: Regional Insights
5.1. Global U.S. Contraceptive Market Data & Future Forecasts, By Region 2016-2027
5.2. North America
5.2.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
5.2.3. U.S.
5.2.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.3.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
5.2.4. Canada
5.2.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
5.3. Europe
5.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
5.3.3. U.K.
5.3.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.3.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
5.3.4. Germany
5.3.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
5.3.5. France
5.3.5.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.5.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
5.4. Asia Pacific
5.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
5.4.3. China
5.4.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.3.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
5.4.4. India
5.4.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
5.4.5. Japan
5.4.5.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.5.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
5.4.6. South Korea
5.4.6.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.6.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
5.5. Latin America
5.5.1. Historic Market Data & Future Forecasts, 2016-2027
5.5.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
5.5.3. Brazil
5.5.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.5.3.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
5.5.4. Mexico
5.5.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.5.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
5.6. Middle East & Africa
5.6.1. Historic Market Data & Future Forecasts, 2016-2027
5.6.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
5.6.3. UAE
5.6.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.6.3.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
5.6.4. South Africa
5.6.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.6.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
Chapter 6. Company Profiles
6.1. AFAXYS, INC.
6.1.1. Company Description
6.1.2. Financial Highlights
6.1.3. Product Portfolio
6.1.4. Strategic Initiatives
6.2. PFIZER, INC
6.2.1. Company Description
6.2.2. Financial Highlights
6.2.3. Product Portfolio
6.2.4. Strategic Initiatives
6.3. ALLERGAN
6.3.1. Company Description
6.3.2. Financial Highlights
6.3.3. Product Portfolio
6.3.4. Strategic Initiatives
6.4. BAYER AG
6.4.1. Company Description
6.4.2. Financial Highlights
6.4.3. Product Portfolio
6.4.4. Strategic Initiatives
6.5. MERCK & CO., INC
6.5.1. Company Description
6.5.2. Financial Highlights
6.5.3. Product Portfolio
6.5.4. Strategic Initiatives
6.6. THE COOPER COMPANIES, INC.
6.6.1. Company Description
6.6.2. Financial Highlights
6.6.3. Product Portfolio
6.6.4. Strategic Initiatives
6.7. APOTHECUS PHARMACEUTICAL CORP.
6.7.1. Company Description
6.7.2. Financial Highlights
6.7.3. Product Portfolio
6.7.4. Strategic Initiatives
6.8. AGILE THERAPEUTICS
6.8.1. Company Description
6.8.2. Financial Highlights
6.8.3. Product Portfolio
6.8.4. Strategic Initiatives
6.9. TEVA PHARMACEUTICAL INDUSTRIES LTD.
6.9.1. Company Description
6.9.2. Financial Highlights
6.9.3. Product Portfolio
6.9.4. Strategic Initiatives
6.10. BLAIREX LABORATORIES, INC.
6.10.1. Company Description
6.10.2. Financial Highlights
6.10.3. Product Portfolio
6.10.4. Strategic Initiatives 
List of Tables
Table 1 U.S. Contraceptive MarketMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 2 U.S. ContraceptiveMarket Data & Future Forecasts, By Region, 2016-2027 (USD Billion)
Table 3 U.S. ContraceptiveMarket Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 4 PillsMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 5 CondomsMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 6 Male CondomsMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 7 Female Condoms Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 8 Diaphragms Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 9 Sponge Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 10 Vaginal Ring Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 11 Subdermal Implants Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 12 IUD Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 13 Hormonal IUD Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 14 Nonhormonal IUD Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 15 Pitch Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 16 Injectable Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 17 North America U.S. ContraceptiveMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 18 North America U.S. ContraceptiveMarket Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 19 U.S. U.S. ContraceptiveMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 20 U.S. U.S. ContraceptiveMarket Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 21 Canada U.S. ContraceptiveMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 22 Canada U.S. ContraceptiveMarket Data & Future Forecasts, By Product, 2016-2027 (USD Billion)

List of Figures
Fig.1 Data Analysis Model
Fig.2U.S. Contraceptive Market, by 2016-2027 (USD Billion)
Fig.3U.S. Contraceptive Market Segmentation
Fig.4Supply chain analysis
Fig.5 U.S. Contraceptive Market Driver Anlaysis
Fig.6 U.S. Contraceptive Market Restraint Analysis
Fig.7 U.S. Contraceptive Market Opportunity Analysis
Fig.8 Porters 5 Forces Model
Fig.9 PEST Analysis- U.S. Contraceptive Market
Fig.10 Company Market Share Analysis, 2019

U.S. Contraceptive Market Segmentation:

U.S. Contraceptive Market, By Product (2016-2027)

  • Pills
  • Condoms
  • Male Condoms
  • Female Condoms
  • Diaphragms
  • Sponge
  • Vaginal Ring
  • Subdermal Implants
  • IUD
  • Hormonal IUD
  • Nonhormonal IUD
  • Patch
  • Injectable

U.S. Contraceptive Market, By Region (2016-2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • South Africa

Major Players Operating in the U.S. Contraceptive Market:

  • AFAXYS, INC.
  • PFIZER, INC
  • ALLERGAN
  • BAYER AG
  • MERCK & CO., INC
  • THE COOPER COMPANIES, INC.
  • APOTHECUS PHARMACEUTICAL CORP.
  • AGILE THERAPEUTICS
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • BLAIREX LABORATORIES, INC.

Choose License Type

Single user
$3,960
Multi User
$4,950
Enterprise User
$5,940
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.